Correlation Between Dev Information and Emcure Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Dev Information and Emcure Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dev Information and Emcure Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dev Information Technology and Emcure Pharmaceuticals, you can compare the effects of market volatilities on Dev Information and Emcure Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dev Information with a short position of Emcure Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dev Information and Emcure Pharmaceuticals.

Diversification Opportunities for Dev Information and Emcure Pharmaceuticals

-0.06

Correlation Coefficient

Dev Information  Emcure Pharmaceuticals

Good diversification

The 3 months correlation between Dev and Emcure is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Dev Information Technology and Emcure Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emcure Pharmaceuticals and Dev Information is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dev Information Technology are associated (or correlated) with Emcure Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emcure Pharmaceuticals has no effect on the direction of Dev Information i.e., Dev Information and Emcure Pharmaceuticals go up and down completely randomly.

Pair Corralation between Dev Information and Emcure Pharmaceuticals

Assuming the 90 days trading horizon Dev Information Technology is expected to generate 2.2 times more return on investment than Emcure Pharmaceuticals. However, Dev Information is 2.2 times more volatile than Emcure Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Emcure Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest  15,613  in Dev Information Technology on October 15, 2024 and sell it today you would earn a total of  1,089  from holding Dev Information Technology or generate 6.97% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Dev Information Technology  vs.  Emcure Pharmaceuticals

Dev Information Tech

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Dev Information Technology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Dev Information displayed solid returns over the last few months and may actually be approaching a breakup point.

Emcure Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Emcure Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Dev Information and Emcure Pharmaceuticals

The main advantage of trading using opposite Dev Information and Emcure Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dev Information position performs unexpectedly, Emcure Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will offset losses from the drop in Emcure Pharmaceuticals' long position.

The idea behind Dev Information Technology and Emcure Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.